Advancing knowledge regarding the biology of chronic inflammation has led to the
development of specific biologic therapies that mechanistically target individual …

Inflammatory bowel disease therapy can be considered in several subcategories, and this
review is designed to provide selective updates for some of the most important therapeutic …

The specific pathogenesis underlining inflammatory bowel disease (IBD) is very
complicated, and it is further more difficult to clearly explain the pathophysiology of 2 major …

Pathophysiology of Inflammatory Bowel Diseases Research on IBDs has identified disrupted
immune responses in the gastrointestinal mucosa and putative disruptions in the gut …

Inflammatory bowel disease (IBD) consists of Crohn's disease (CD) and ulcerative colitis
(UC). It is thought to be caused by genetic, abnormal immune response of the intestinal …

Inflammatory bowel disease pathogenesis: what is new? : Current Opinion in
Gastroenterology Inflammatory bowel disease pathogenesis: what is new? : Current …

Inflammatory bowel disease patients frequently use herbal products as complementary or
alternative medicines to current pharmacotherapies and obtain information on them mainly …

Inflammatory bowel diseases (IBDs) are characterized by autoimmune and inflammation‐
related complications of the large intestine (ulcerative colitis) and additional parts of the …

The current understanding of inflammatory bowel disease (IBD) pathogenesis implicates a
complex interaction between host genetics, host immunity, microbiome, and environmental …

Inflammatory bowel disease (IBD) is a rare, recurrent, and intractable inflammation
obstruction of the stomach tract, usually accompanied by inflammation of cell proliferation …